S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in

AIkido Pharma Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
+0.05 (+4.95 %)
(As of 03/5/2021 12:00 AM ET)
Today's Range
Now: $1.06
50-Day Range
MA: $1.60
52-Week Range
Now: $1.06
Volume11.66 million shs
Average Volume22.53 million shs
Market Capitalization$86.70 million
P/E RatioN/A
Dividend YieldN/A
AIkido Pharma, Inc. is a biotechnology development company, which engages in the provision of diversified commercialization platform for protected technologies. The firm's activities include the acquisition and development of patents through internal or external research and development. Its patent portfolio consists of patents in the fields of wireless communications, satellite, solar and radio frequency, as well as 2 U.S. patents in pharmaceutical technology. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.


See More Headlines

Industry, Sector and Symbol

Industry Commercial physical research
Current SymbolNASDAQ:AIKI
Phone(703) 992-9325
Year FoundedN/A



Sales & Book Value

Annual Sales$10,000.00
Book Value$2.18 per share


Net Income$-4,180,000.00


Market Cap$86.70 million
Next Earnings Date5/12/2021 (Estimated)
OptionableNot Optionable


Overall MarketRank

0.63 out of 5 stars

Medical Sector

1318th out of 1,968 stocks

Commercial Physical Research Industry

24th out of 42 stocks

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Receive AIKI News and Ratings via Email

Sign-up to receive the latest news and ratings for AIKI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

AIkido Pharma (NASDAQ:AIKI) Frequently Asked Questions

What stocks does MarketBeat like better than AIkido Pharma?

Wall Street analysts have given AIkido Pharma a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AIkido Pharma wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting AIkido Pharma?

AIkido Pharma saw a decrease in short interest during the month of February. As of February 12th, there was short interest totaling 690,400 shares, a decrease of 41.5% from the January 28th total of 1,180,000 shares. Based on an average trading volume of 16,430,000 shares, the short-interest ratio is presently 0.0 days. Approximately 2.0% of the shares of the company are sold short.
View AIkido Pharma's Short Interest

When is AIkido Pharma's next earnings date?

AIkido Pharma is scheduled to release its next quarterly earnings announcement on Wednesday, May 12th 2021.
View our earnings forecast for AIkido Pharma

Who are AIkido Pharma's key executives?

AIkido Pharma's management team includes the following people:
  • Anthony C. Hayes, CEO, Principal Financial Officer & Director
  • Tom Wilkie, Chief Science Officer
  • Jane H. Behrmann, Office Manager

Who are some of AIkido Pharma's key competitors?

What other stocks do shareholders of AIkido Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AIkido Pharma investors own include Biocept (BIOC), AIM ImmunoTech (AIM), CHF Solutions (CHFS), Foresight Autonomous (FRSX), iBio (IBIO), Exela Technologies (XELA), Bionano Genomics (BNGO), Check-Cap (CHEK), Digital Ally (DGLY) and Purple Biotech (KTOV).

What is AIkido Pharma's stock symbol?

AIkido Pharma trades on the NASDAQ under the ticker symbol "AIKI."

Who are AIkido Pharma's major shareholders?

AIkido Pharma's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Virtu Financial LLC (0.25%).
View institutional ownership trends for AIkido Pharma

Which major investors are buying AIkido Pharma stock?

AIKI stock was purchased by a variety of institutional investors in the last quarter, including Virtu Financial LLC.
View insider buying and selling activity for AIkido Pharma
or or view top insider-buying stocks.

What is AIkido Pharma's stock price today?

One share of AIKI stock can currently be purchased for approximately $1.06.

How much money does AIkido Pharma make?

AIkido Pharma has a market capitalization of $86.70 million and generates $10,000.00 in revenue each year.

How many employees does AIkido Pharma have?

AIkido Pharma employs 3 workers across the globe.

What is AIkido Pharma's official website?

The official website for AIkido Pharma is www.spherix.com.

Where are AIkido Pharma's headquarters?

AIkido Pharma is headquartered at ONE ROCKEFELLER PLAZA 11TH FLOOR, NEW YORK NY, 10020.

How can I contact AIkido Pharma?

AIkido Pharma's mailing address is ONE ROCKEFELLER PLAZA 11TH FLOOR, NEW YORK NY, 10020. The business services provider can be reached via phone at (703) 992-9325 or via email at [email protected]

This page was last updated on 3/7/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.